AI assistant
CME GROUP INC. — Director's Dealing 2020
Mar 2, 2020
29871_dirs_2020-03-02_0107bd0b-a4c9-4bb2-91b1-31bc254eb07f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2020-02-28
Reporting Person: Holzrichter Julie (Sr MD Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-28 | Common Stock Class A | S | 3061 | $203.37 | Disposed | 37284 | Direct |
Footnotes
F1: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.
F2: On February 28, 2020, Ms. Holzrichter sold an aggregate of 3,061 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $199.46 to $199.82; $200.01 to $200.5; $205 to $205.98; $206.13 to $206.57; $207.34 to $207.72; and $208.54. The Company maintains a record of the transactions and copies will be provided upon request.